MOLECULAR INSIGHT
Live / Registered — Registered and renewed (as of 27 Jan 2018)
What this means for you
Registered since 10 Jul 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Jul 2017).
Record
- Serial number
- 76582783
- Registration number
- 3261505
- Mark type
- Word mark
- Filed
- 22 Mar 2004
- Published for opposition
- 27 Sept 2005
- Registered
- 10 Jul 2007
- Next maintenance due
- 10 Jul 2017
- Attorney of record
- Phi Lan Tinsley
Goods and services
- Class 005 — Pharmaceuticals: Radiological, radiopharmaceutical and medicinal agents and preparations for the detection, screening, diagnosis and/or treatment of cancer, cardiac disease and neurological disorders
Owner
- Molecular Insight Pharmaceuticals, Inc., New York, NY, US
- Molecular Insight Pharmaceuticals, Inc., Cambridge, MA, US
- Molecular Insight Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 16 Sept 2020 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 27 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 27 Jan 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 27 Jan 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 27 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Jan 2018 — TEAS SECTION 8 & 9 RECEIVED
- 01 Feb 2017 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 01 Feb 2017 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 Jul 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 25 Jul 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
- 24 Jul 2013 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 24 Jul 2013 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 24 Jul 2013 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Jul 2013 — TEAS SECTION 8 & 15 RECEIVED
- 23 Jan 2013 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY